Anamnèse familiale: utile ou futile? (Record no. 61456)

000 -LEADER
fixed length control field 02245nab a2200313za 4500
001 - CONTROL NUMBER
control field 61456
003 - CONTROL NUMBER IDENTIFIER
control field CHUV
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20160413164806.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field tu
019 ## - DOCUMENT TYPE
Document type Article
035 ## - SYSTEM CONTROL NUMBER
System control number (Alexandrie)18770203
035 ## - SYSTEM CONTROL NUMBER
System control number (Saphir)77822
035 ## - SYSTEM CONTROL NUMBER
System control number (PubMed ID)19267055
040 ## - CATALOGING SOURCE
Original cataloging agency DI / Base externe
041 ## - LANGUAGE CODE
Language code of text/sound track or separate title fre
100 ## - MAIN ENTRY--PERSONAL NAME
9 (RLIN) 49302
Personal name Bochud, Murielle
119 ## - DEPOT INSTITUTIONNEL
Dépôt institutionnel DUMSC
-- IUMSP
245 ## - TITLE STATEMENT
Title Anamnèse familiale: utile ou futile?
Medium [article]
500 ## - GENERAL NOTE
General note Titre traduit: Family history: useful or futile?
520 ## - SUMMARY, ETC.
Summary, etc L'anamnèse familiale (AF) est un outil important en pratique clinique permettant d'évaluer un risque accru de développer certaines maladies car elle tient compte de facteurs génétiques et environnementaux présents dans une famille. L'AF a montré son utilité dans des situations comme le diabète de type 2 ou les maladies cardiovasculaires car elle identifie des sujets qui bénéficient potentiellement de mesures de prise en charge diagnostique ou préventive spécifiques. Nous montrons aussi que, malgré les progrès récents en génétique moléculaire, l'AF garde toute son importance et qu'elle est probablement sous-utilisée. [Auteurs] [Abstract] Family history (FH) represents an important tool in clinical practice that allows assessing an increased risk to develop certain diseases as it captures genetic and environmental factors within a family. FH was shown to be important for several conditions such as type 2 diabetes mellitus and cardiovascular diseases as it allows identifying subjects who can potentially benefit from specific diagnostic and therapeutic measures. We also show that FH rernains an important tool even in this period of recent progress in molecular genetics and that it is probably underused in the clinical setting. [Authors]
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 46653
Personal name Waeber, Gérard
700 ## - ADDED ENTRY--PERSONAL NAME
9 (RLIN) 46654
Personal name Vollenweider, Peter
773 ## - HOST ITEM ENTRY
Title Revue médicale suisse
Place, publisher, and date of publication 2009
Relationship information 5, 188 (2009), 263-267
Display text In
Issue 188
-- 263-267
Volume 5
856 4# - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://rms.medhyg.ch/numero-188-page-263.htm
Public note Date de consultation : 29.01.2009
970 ## - LOCAL SUBJECT ADDED ENTRY-- MESH
9 (RLIN) 12508
Term Family
970 ## - LOCAL SUBJECT ADDED ENTRY-- MESH
9 (RLIN) 14036
Term Genetic Diseases, Inborn
970 ## - LOCAL SUBJECT ADDED ENTRY-- MESH
9 (RLIN) 20830
Term Medical History Taking
970 ## - LOCAL SUBJECT ADDED ENTRY-- MESH
9 (RLIN) 14040
Term Genetic Diseases, Inborn
General subdivision genetics
Holdings
Not for loan Withdrawn status Current Location Damaged status Date last seen Price effective from Permanent Location Full call number Lost status Date acquired
Disponible IST, Institut universitaire romand de santé au travail; Bibliothèque 2016-04-132016-04-13IST, Institut universitaire romand de santé au travail; BibliothèquePUB-ART-REGIO 2009-07-23